Ezutromid

DB12888InvestigationalSmall molecule

Ezutromid has been investigated for the treatment of Muscular Dystrophy, Duchenne.

Chemical structure of Ezutromid
Mechanism
Curator reviewed
Formula / weight
C19H15NO3S · 337.39 g/mol (avg)
Also known as
5-(Ethylsulfonyl)-2-(naphthalen-2-yl)benzo(d)oxazole · Benzoxazole, 5-(ethylsulfonyl)-2-(2-naphthalenyl)-
Code names
BMN-195 · SMT-C1100

Resolves to

Compound
UNII645R07LF0DCAS945531-77-1ChEMBLCHEMBL1773683PubChem25109292
Structure
InChIKeyKSGCNXAZROJSNW-UHFFFAOYSA-NSMILESCCS(=O)(=O)C1=CC=C2OC(=NC2=C1)C1=CC=C2C=CC=CC2=C1
Targets
P46939UTRN

What you can answer from here — as of August 27, 2024

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
2Clinical trialsPhase, status and sponsor resolved per trial
Sign in
4+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Ezutromid, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In